Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
5.43
+0.65 (13.60%)
At close: Nov 4, 2024, 4:00 PM
5.49
+0.06 (1.10%)
After-hours: Nov 4, 2024, 4:52 PM EST
Treace Medical Concepts Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 338 | 786 | 1,276 | 991 | - | - |
| Market Cap Growth | -73.72% | -38.37% | 28.74% | - | - | - |
| Enterprise Value | 272 | 735 | 1,259 | 911 | - | - |
| Last Close Price | 4.78 | 12.75 | 22.99 | 18.64 | - | - |
| PE Ratio | - | -15.67 | -29.68 | -43.50 | - | - |
| PS Ratio | 1.49 | 4.20 | 9.00 | 10.50 | - | - |
| PB Ratio | 2.65 | 5.70 | 21.08 | 10.65 | - | - |
| P/FCF Ratio | -9.93 | -17.08 | -28.05 | -49.81 | - | - |
| P/OCF Ratio | -13.70 | -22.74 | -41.63 | -57.65 | - | - |
| EV/Sales Ratio | 1.37 | 3.93 | 8.88 | 9.65 | - | - |
| EV/EBITDA Ratio | -6.43 | -15.84 | -38.50 | -57.58 | - | - |
| EV/EBIT Ratio | -5.75 | -14.33 | -36.14 | -55.19 | - | - |
| EV/FCF Ratio | -8.97 | -15.96 | -27.69 | -45.79 | - | - |
| Debt / Equity Ratio | 0.62 | 0.51 | 1.13 | 0.32 | 40.23 | 6.08 |
| Debt / EBITDA Ratio | - | - | - | - | 15.12 | - |
| Debt / FCF Ratio | -1.68 | -1.53 | -1.51 | -1.48 | -5.61 | -2.16 |
| Asset Turnover | 0.83 | 0.91 | 0.95 | 1.03 | 1.60 | - |
| Inventory Turnover | 1.14 | 1.45 | 1.71 | 1.84 | 1.86 | - |
| Quick Ratio | 2.73 | 3.61 | 3.67 | 6.83 | 2.81 | 3.08 |
| Current Ratio | 3.86 | 4.40 | 4.41 | 7.58 | 3.53 | 3.90 |
| Return on Equity (ROE) | -48.60% | -49.91% | -55.75% | -43.80% | -186.33% | - |
| Return on Assets (ROA) | -17.02% | -15.59% | -14.53% | -11.30% | 1.49% | - |
| Return on Capital (ROIC) | -20.12% | -18.99% | -17.30% | -13.35% | 1.97% | - |
| Earnings Yield | -21.42% | -6.30% | -3.36% | -2.07% | - | - |
| FCF Yield | -13.96% | -5.85% | -3.56% | -2.01% | - | - |
| Buyback Yield / Dilution | -6.96% | -10.09% | -14.17% | -30.61% | -0.43% | - |
| Total Shareholder Return | -6.96% | -10.09% | -14.17% | -30.61% | -0.43% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.